BRCA1 and BRCA2 Testing in Medically Underserved Medicare Beneficiaries With Breast or Ovarian Cancer

Amy L Gross; William J Blot; Kala Visvanathan

doi:10.1001/jama.2018.8258

BRCA1 and BRCA2 Testing in Medically Underserved Medicare Beneficiaries With Breast or Ovarian Cancer

JAMA. 2018 Aug 14;320(6):597-598. doi: 10.1001/jama.2018.8258.

Authors

Amy L Gross¹, William J Blot², Kala Visvanathan³

Affiliations

¹ Vanderbilt Institute for Clinical and Translational Research, Vanderbilt University Medical Center, Nashville, Tennessee.
² Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee.
³ Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.

Abstract

This study uses US community cohort data to assess BRCA1 and BRCA2 testing among medically underserved Medicare beneficiaries with breast cancer, ovarian cancer, or both.

MeSH terms

Aged
Breast Neoplasms / genetics*
Cohort Studies
Female
Genes, BRCA1*
Genes, BRCA2*
Genetic Testing / statistics & numerical data*
Germ-Line Mutation
Humans
Insurance Coverage
Medically Underserved Area*
Medicare*
Middle Aged
Ovarian Neoplasms / genetics*
United States